Delaware-based Incyte is now turning to AI to power through the coming decades.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, nd more.

Delaware-based Incyte is now turning to AI to power through the coming decades.